... References
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
The Impact of HIV on Hispanic/Latino People in the United States — KFF
HIV Among Latinos — League of United Latin American Citizens
Putting a Number on It: The Risk From an Exposure to HIV — Stanford Medicine
Estimated HIV Risk Per Exposure — Aidsmap
...
Probabilidad de contagio de VIH en una sola exposición: todo lo que necesita saber
... References
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
The Impact of HIV on Hispanic/Latino People in the United States — KFF
HIV Among Latinos — League of United Latin American Citizens
Putting a Number on It: The Risk From an Exposure to HIV — Stanford Medicine
Estimated HIV Risk Per Exposure — Aidsmap
...
... and Prevention
CD4 Lymphocyte Count — MedLine Plus
HIV Treatment as Prevention — Centers for Disease Control and Prevention
Ways HIV Is Not Transmitted — Centers for Disease Control and Prevention
...
... Referencias
Switch to Single-Tablet Bictegravir-Lenacapavir From a Complex HIV Regimen (Artistry-1): A Randomised, Open-Label, Phase 3 Clinical Trial — The Lancet
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy — Gilead
...
... Sleep — Mayo Clinic
Myths and Facts About Sleep — Sleep Foundation
Fatigue Is Associated With Worse Cognitive and Everyday Functioning in Older Persons With HIV — AIDS ...
... Food and Drug Administration
FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo — Drugs.com
Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection — Gilead
Drug Database: Cabotegravir — Clinicalinfo.HIV.gov
VIH/sida — Mayo Clinic
Barriers to HIV Medication Adherence as a Function ...
Cómo funcionan los medicamentos inyectables para tratar y prevenir el VIH
... Food and Drug Administration
FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo — Drugs.com
Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection — Gilead
Drug Database: Cabotegravir — Clinicalinfo.HIV.gov
VIH/sida — Mayo Clinic
Barriers to HIV Medication Adherence as a Function ...
... Department of Veterans Affairs
Stigma and HIV — Centers for Disease Control and Prevention
Supporting Retention in HIV Care Through a Holistic, Patient-Centred Approach: A Qualitative Evaluation — BMC Psychology
HIV Treatment as Prevention — Centers for Disease Control and Prevention ...
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
CBD para el VIH: ¿es eficaz?
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
... Food and Drug Administration ...
... — HIV.gov
Management of Health Care Personnel Exposed to HIV — Wolters Kluwer UpToDate
Preguntas frecuentes con relación al VIH y el sida — ONUSIDA
Harm Reduction To Lessen HIV Risks — National Institute of Allergy and Infectious Diseases
Profilaxis posexposición (PEP) — HIVinfo
Prueba de carga viral — MedlinePlus
...
¿Se puede contagiar el VIH al compartir bebidas o besarse?
... — HIV.gov
Management of Health Care Personnel Exposed to HIV — Wolters Kluwer UpToDate
Preguntas frecuentes con relación al VIH y el sida — ONUSIDA
Harm Reduction To Lessen HIV Risks — National Institute of Allergy and Infectious Diseases
Profilaxis posexposición (PEP) — HIVinfo
Prueba de carga viral — MedlinePlus
...
únete
Tus opciones de privacidad
